Literature DB >> 6328955

Regulation of histidine decarboxylase activity in rat hypothalamus in vitro by ATP and cyclic AMP: enzyme inactivation under phosphorylating conditions.

Z Huszti, K Magyar.   

Abstract

In vitro, hypothalamic HD1 from rat, could strikingly be inhibited by ATP and cyclic AMP. The enzyme inhibition is partially dependent upon Mg2+ and the circumstances favourable for a cAMP-dependent phosphorylation. An almost complete inhibition could be achieved by incubating the homogenate of the hypothalamus under phosphorylating conditions (ATP, cAMP, Mg2+ and IBMX) in the presence of a cAMP-dependent protein kinase (obtained from bovine thymus). Cyclic nucleotides and ATP alone elicit only moderate inhibitions on the hypothalamic HD activity. Neither ATP, nor cAMP, added alone or in combinations, alter the total brain or the hypothalamic HNMT from guinea-pigs or rats in concentrations up to 10(-3) M. Results suggest that hypothalamic HD is regulated through a cAMP-dependent process, probable a direct phosphorylation, via a cAMP-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328955     DOI: 10.1007/bf01973868

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

1.  Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities.

Authors:  P A Insel; J Fenno
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation.

Authors:  T H Joh; D H Park; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.

Authors:  M Goldstein; R L Bronaugh; B Ebstein; C Roberge
Journal:  Brain Res       Date:  1976-06-18       Impact factor: 3.252

4.  Isotopic microassay of histamine, histidine, histidine decarboxylase and histamine methyltransferase in brain tissue.

Authors:  K M Taylor; S H Snyder
Journal:  J Neurochem       Date:  1972-05       Impact factor: 5.372

Review 5.  Cyclic AMP.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Annu Rev Biochem       Date:  1968       Impact factor: 23.643

6.  Regulation of histamine synthesis: altered synthesis and level of histamine in the hypothalamus of rats by repeated administration of histamine H1 and H2 receptor antagonists.

Authors:  Z Huszti
Journal:  Agents Actions       Date:  1980-04

7.  Histamine-sensitive adenylate cyclase in hypothalamus of rat brain: H1 and H2 receptors.

Authors:  P Portaleone; G Pagnini; A Crispino; E Genazzani
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

8.  Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP.

Authors:  J E Harris; V H Morgenroth; R H Roth; R J Baldessarini
Journal:  Nature       Date:  1974-11-08       Impact factor: 49.962

9.  Regulatory influence of histamine receptor activation and inhibition on the synthesis and level of hypothalamic histamine.

Authors:  Z Huszti; K Magyar
Journal:  Agents Actions       Date:  1984-06
  9 in total
  5 in total

1.  Effects of various compounds on histidine decarboxylase activity: active site mapping.

Authors:  Y Sakamoto; T Watanabe; H Hayashi; Y Taguchi; H Wada
Journal:  Agents Actions       Date:  1985-10

2.  Stimulation of hypothalamic histidine decarboxylase by calcium-calmodulin and protein kinase (cAMP-dependent) inhibitor.

Authors:  Z Huszti; K Magyar
Journal:  Agents Actions       Date:  1987-04

3.  Histamine, histidine decarboxylase and histamine-N-methyltransferase in brain areas of spontaneously hypertensive rats.

Authors:  H Prast; V Gujrati; S Walser; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

4.  Characterization and expression of the complementary DNA encoding rat histidine decarboxylase.

Authors:  D R Joseph; P M Sullivan; Y M Wang; C Kozak; D A Fenstermacher; M E Behrendsen; C A Zahnow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Evidence for the role of cAMP-dependent protein kinase in the down-regulation of hypothalamic HD: reversal of cAMP-(ATP) induced inhibition of HD activity by the 'Walsh' inhibitor of cAMP-dependent protein kinase and by cyclic GMP.

Authors:  Z Huszti; K Magyar
Journal:  Agents Actions       Date:  1985-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.